|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Mount Sinai School of Medicine |
|---|---|
| Collaborator: |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Information provided by: | Mount Sinai School of Medicine |
| ClinicalTrials.gov Identifier: | NCT00439985 |
Purpose
| Condition | Intervention |
|---|---|
|
Type 1 Diabetes Mellitus |
Behavioral: Cognitive Behavioral Therapy |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study |
Eligibility| Ages Eligible for Study: | 7 Years to 11 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Claude Chemtob, Ph.D. | 212-987-0030 | Claude.Chemtob@mssm.edu |
| United States, New York | |
| Mount Sinai School of Medicine | Recruiting |
| New York, New York, United States, 10029-6574 | |
| Contact: Claude Chemtob, Ph.D. 212-987-0030 Claude.Chemtob@mssm.edu | |
| Principal Investigator: Claude Chemtob, Ph.D. | |
| Principal Investigator: | Claude Chemtob, Ph.D. | Mount Sinai School of Medicine |
More Information
| Study ID Numbers: | DK074580, 05-0667 |
| Study First Received: | February 23, 2007 |
| Last Updated: | May 23, 2008 |
| ClinicalTrials.gov Identifier: | NCT00439985 History of Changes |
| Health Authority: | United States: Institutional Review Board |
|
Type 1 Diabetes Mellitus (T1DM) Metabolic Control Adherence |
Optimism Parent-Child Collaboration Prevention |
|
Autoimmune Diseases Metabolic Diseases Immune System Diseases Diabetes Mellitus, Type 1 |
Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders |